Chemoinformaics analysis of CYANIDIN-3-O-RUTINOSIDE
| Molecular Weight | 595.53 | nRot | 6 |
| Heavy Atom Molecular Weight | 564.282 | nRig | 29 |
| Exact Molecular Weight | 595.166 | nRing | 5 |
| Solubility: LogS | -3.045 | nHRing | 3 |
| Solubility: LogP | -0.602 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 73 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 2 |
| nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 31 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
| nHA | 14 | APOL | 77.7906 |
| nHD | 10 | BPOL | 39.7794 |
| QED | 0.124 |
| Synth | 4.96 |
| Natural Product Likeliness | 1.977 |
| NR-PPAR-gamma | 0.949 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.965 |
| HIA | 0.942 |
| CACO-2 | -6.398 |
| MDCK | 0.0000344 |
| BBB | 0.195 |
| PPB | 0.840568 |
| VDSS | 0.706 |
| FU | 0.22756 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.026 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.055 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.151 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.176 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.003 |
| CL | 1.866 |
| T12 | 0.565 |
| hERG | 0.008 |
| Ames | 0.671 |
| ROA | 0.074 |
| SkinSen | 0.048 |
| Carcinogencity | 0.14 |
| EI | 0.011 |
| Respiratory | 0.022 |
| NR-Aromatase | 0.934 |
| Antiviral | Yes |
| Prediction | 0.834314 |